Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy Subjects
- First Posted Date
- 2022-07-26
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Pieris Australia Pty Ltd
- Target Recruit Count
- 64
- Registration Number
- NCT05473533
- Locations
- 🇦🇺
Nucleus Network Pty Ltd., Melbourne, Victoria, Australia
Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma
- First Posted Date
- 2018-07-02
- Last Posted Date
- 2020-12-24
- Lead Sponsor
- Pieris Australia Pty Ltd
- Target Recruit Count
- 76
- Registration Number
- NCT03574805
- Locations
- 🇦🇺
Q-Pharm, Herston, Queensland, Australia
🇦🇺CMAX, Adelaide, South Australia, Australia
🇦🇺Nucleus Network Limited, Melbourne, Victoria, Australia
Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects
- First Posted Date
- 2017-12-27
- Last Posted Date
- 2020-11-16
- Lead Sponsor
- Pieris Australia Pty Ltd
- Target Recruit Count
- 72
- Registration Number
- NCT03384290
- Locations
- 🇦🇺
Nucleus Network Limited, Melbourne, Victoria, Australia
News
No news found